Pacific Biosciences proposes $75M stock offering Aug. 11, 2020 4:44 PM ET Pacific Biosciences of California, Inc. (PACB) By: Shweta Agarwal , SA News Editor 13 Comments After a Post-Earnings Drop, is it Time to Ride PetMed Express? Since then, PACB stock has increased by 987.8% and is now trading at $37.42. View which stocks have been most impacted by COVID-19. Pacific Biosciences of California Inc. stock is now 45.41% up from its year-to-date (YTD) trading value. Shares of PACB can be purchased through any online brokerage account. Pacific Biosciences of California's stock was trading at $3.44 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. This puts Doug Parker in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies. Piper Sandler currently has a neutral rating on the stock. Pacific Biosciences of California Inc. advanced stock charts by MarketWatch. Man Who Predicted March 2020 Crash Says 2021 Is The Time. View our full suite of financial calendars and market data tables, all for free. Veröffentlichung... DGAP-Ad-hoc: KROMI Logistik AG / Schlagwort(e): Übernahmeangebot/Gewinnwarnung 143. (Add your “outperform” vote. 2020: WALL STREET STOCK EXCHANGE: Les valeurs à suivre à Wall Street: 2020: WALL STREET STOCK EXCHANGE: USA-Les valeurs à suivre à Wall Street (actualisé): 2015: PACIFIC BIOSCIENCES OF CALIFORNIA: stellt neue, auf seiner SMRT-Technologie bas..: 2015: PACIFIC BIOSCIENCES OF CALIFORNIA: lance une nouvelle plate-forme de séquençage..: 2013: PACIFIC BIOSCIENCES OF … Die BB Biotech AG (ISIN: CH0038389992) entwickelte sich 2020 in einem volatilen Marktumfeld positiv. The company serves research institutions; commercial laboratories; genome centers; clinical, government, and academic institutions; genomics service providers; pharmaceutical companies; and agricultural companies. Relative to other stocks in its sector (Healthcare), Pacific Biosciences … Get today's Pacific Biosciences of California stock price and latest PACB news as well as Pacific Biosciences real-time stock quotes, technical analysis, full financials and more. 0. Nachrichten zur Aktie Pacific Biosciences of California Inc | A1C3EQ | PACB | US69404D1081 To see all exchange delays and terms of use please see disclaimer. Pinterest . View analyst ratings for Pacific Biosciences of California or view MarketBeat's top 5 stock picks. Heidelberg Pharma AG: Vorabbekanntmachung über... (shareribs.com) Frankfurt / New York 14.01.2021 - Biotech-Aktien zeigten sich im deutschen Handel überwiegend fester. Pacific Biosciences of California trades on the NASDAQ under the ticker symbol "PACB.". The stock has … Why You Should Retain Pacific Biosciences (PACB) Stock Now - January 20, 2021 - … Für BioFrontera ging es dabei deutlich nach oben. MENLO PARK, Calif., Nov. 11, 2020 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (Nasdaq: PACB) (“Pacific Biosciences” or the “Company”) today announced that it has priced its previously announced underwritten public offering of an aggregate of 7,400,460 shares of its common stock at a price to the public of $14.25 per share. MarketBeat thinks these five stocks may be even better buys.View MarketBeat's top stock picks here. Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. In addition, it provides binding kits, such as modified DNA polymerase used to bind SMRTbell libraries to the polymerase in preparation for sequencing; and sequencing kits comprises reagents required for on-instrument, real-time sequencing, including the phospholinked nucleotides. 326 E 8th St #105, Sioux Falls, SD 57103 | [email protected] | (844) 978-6257 Pacific Biosciences of California employs 404 workers across the globe. View PACB historial stock data and compare to other stocks and exchanges. A high-level overview of Pacific Biosciences of California, Inc. (PACB) stock. Stacy Lee - December 22, 2020. MENLO PARK, Calif., Jan. 08, 2021 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ: PACB), a leading provider of high-quality sequencing solutions, today announced the appointments of Mark Van Oene as Chief Operating Officer and Peter Fromen as Chief Commercial Officer, both effective as of January 8, 2021. Pacific Biosciences of California, Inc. PACB is well poised for growth, backed by a robust progress in its Sequel System as well as its sequencing technology. Pacific Biosciences of California, Inc. PACB 36.31 2.28 (5.90%). Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. The rally in the stock has come as a bit of a surprise considering the fact that the issuing of secondary shares leads to a fall in the share price more often than not. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. The biotechnology company reported ($0.14) earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of ($0.13) by $0.01. Some companies that are related to Pacific Biosciences of California include Thermo Fisher Scientific (TMO), Illumina (ILMN), Agilent Technologies (A), Mettler-Toledo International (MTD), Bio-Rad Laboratories (BIO), PerkinElmer (PKI), Waters (WAT), Charles River Laboratories International (CRL), Bio-Techne (TECH), Bruker (BRKR), Luminex (LMNX), Fluidigm (FLDM), Harvard Bioscience (HBIO), aTyr Pharma (LIFE) and BG Medicine (BGMD). You may vote once every thirty days. It markets its products through a direct sales force in North America and Europe, as well as through distribution partners in Asia, Europe, the Middle East, Africa, and Latin America. 7 Electric Vehicle (EV) Stocks That Have Real Juice, 7 Post-Inauguration Stocks to Buy For Under $20, 7 Cryptocurrencies That Are Leading The Market Higher, 7 Stocks to Support Your New Year’s Resolutions, 7 Things You Need To Know About Cryptocurrency, 7 Stocks to Buy As Americans Receive Stimulus Checks, 7 Outdoor Recreation Stocks For Growth And Dividends, 8 EV Stocks To Electrify Your Growth Portfolio, view Wall Street analyst' top-rated stocks, Charles River Laboratories International (CRL), Receive Analysts' Upgrades and Downgrades Daily. Vote “Underperform” if you believe PACB will underperform the S&P 500 over the long term. ), Pacific Biosciences of California has received 340 “underperform” votes. Pacific Biosciences of California, Inc. is an American biotechnology company founded in 2004 that develops and manufactures systems for gene sequencing and some novel real time biological … Good News For Pacific Biosciences of California, Inc. (NASDAQ:PACB): Stock Could Rise Another 8.51%. A copy of the press release dated January 13, 2021 announcing the multi-year co-development agreement between Invitae Corporation and Pacific Biosciences of California, Inc. is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference. We will achieve these goals by adhering to and maintaining an effective quality-management system designed to ensure product quality, performance, and safety. Pacific Biosciences of California Inc. (PACB) had a good day on the market for Friday January 22 as shares jumped 3.06% to close at $37.42. Relative to other stocks in its sector (Healthcare), Pacific Biosciences Of California Inc has a … Pacific Biosciences of California's stock was trading at $3.44 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Their forecasts range from $12.00 to $45.00. Only 11.60% of the stock of Pacific Biosciences of California is held by insiders. Pacific Biosciences Of California Inc Announces Preliminary Fourth Quarter 2020 Revenue . Pacific Biosciences of California Inc. (NASDAQ:PACB) went up by 8.87% from its latest closing price compared to the recent 1-year high of $40.77. PACB Stock saw the intraday high of $38.53 and lowest of $34.28 per share. Announces Pricing of Public Offering of Common Stock Tuesday, August 11, 2020 MENLO PARK, Calif., Aug. 11, 2020 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq: PACB) (“Pacific Biosciences” … MarketBeat's community ratings are surveys of what our community members think about Pacific Biosciences of California and other stocks. (Add your “underperform” vote.). 4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Pacific Biosciences of California in the last year. Investor confidence is high on Pacific Biosciences (PACB) stock, courtesy of solid prospects. Image Use Agreement. The company’s stock price has collected 16.25% of gains in the last five trading sessions. Pacific Biosciences of California does not have a long track record of dividend growth. MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. CubeSmart (NYSE: CUBE) Stock is a Smart Pullback Play, Capstone Turbine (NASDAQ: CPST) Stock a Clean Energy Turbine Play, 3D Printing Stocks Offering Another Dimension of Gains, MicroStrategy (NASDAQ:MSTR) Slips on Troubles in Bitcoin. ET on Zacks.com Pacific Biosciences (PACB) Up 41.2% Since Last Earnings Report: Can It Continue? See what's happening in the market right now with MarketBeat's real-time news feed. Jan 11, 2021. About 3.47 million shares traded hands on 30,233 trades Overview. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. Twitter. Post-Market 0.24 (0.66%) Since then, PACB shares have increased by 1,081.7% and is now trading at $40.65. X. Pacific Biosciences of California Inc. (NASDAQ:PACB) went up by 0.09% from its latest closing price compared to the recent 1-year high of $17.10. Pacific Biosciences of California's mailing address is 1305 O`BRIEN DRIVE, MENLO PARK CA, 94025. Pre-Market earnings guidance on Monday, January, 11th. View today's stock price, news and analysis for Pacific Biosciences of California Inc. (PACB). Pacific Biosciences Of California Inc's effective tax rate, as measured by taxes paid relative to net income, is at 0 -- greater than only 0% of US stocks with positive free cash flow. Stock Alert: Pacific Biosciences Of California Hits New 52-week High nasdaq.com - October 2 at 1:12 PM: Are You Looking for a Top Momentum Pick? Christina Lake Cannabis: Blendende Aussichten für 2021 - Rock and Roll! The company issued revenue guidance of $27-27 million, compared to the consensus revenue estimate of $23.69 million. Get the hottest stocks to trade every day before the market opens … All rights reserved. Pacific Biosciences of California Stock News NASDAQ: PACB Pacific Biosciences of California prices equity offering (NASDAQ:PACB) 10:44am, Wednesday, 11'th Nov 2020 Pacific Biosciences of California (NASDAQ:PACB) has priced underwritten public offering of ~7.4M shares at $14.25/share, for gross proceeds of ~$86.9M. MENLO PARK, Calif., Jan. 11, 2021 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (the “Company”) (NASDAQ: PACB), a leading provider of high-quality sequencing … Specifically, they have bought $0.00 in company stock and sold $59,705,787.00 in company stock. Company insiders that have sold Pacific Biosciences of California company stock in the last year include James Michael Phillips, Michael Hunkapiller, and Susan K Barnes. Pacific Biosciences of California had a negative return on equity of 101.30% and a negative net margin of 57.25%. Announces Third Quarter 2020 Financial Results PACB stock was sold by a variety of institutional investors in the last quarter, including Sowell Financial Services LLC. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Doug Parker has an approval rating of 60% among Pacific Biosciences of California's employees. PDF Version . P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Learn everything you need to know about successful options trading with this three-part video course. MENLO PARK, Calif., Jan. 12, 2021 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ: PACB) (“Pacific Biosciences” or the “Company”), a leading provider of high-quality, long read sequencing platforms, today announced that the Board of Directors granted non-qualified stock options. The biotechnology company can be reached via phone at 650-521-8000 or via email at [email protected]. Fundamental company data provided by Morningstar and Zacks Investment Research. Want to see which stocks are moving? Wie aus aktualisierten Handlungsempfehlungen von... NEW YORK (dpa-AFX Broker) - Die US-Bank JPMorgan hat die Einstufung für Morphosys nach der Healthcare Conference der US-Bank auf "Overweight" mit einem Kursziel von 130 Euro belassen. View which stocks have been most impacted by COVID-19. Pacific Biosciences of California, Inc. engages in the development, manufacture and sale of an integrated platform for genetic analysis. The company’s stock price has collected … Get short term trading ideas from the MarketBeat Idea Engine. Pacific Biosciences of California, Inc. has collaboration with Invitae Corporation to develop ultra-high-throughput clinical whole genome sequencing platform. Learn more. Learn more. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. 84.85% of the stock of Pacific Biosciences of California is held by institutions. Breaking News! There are currently 2 hold ratings and 2 buy ratings for the stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. VENLO (Dow Jones)--Qiagen startet einen erneuten Versuch für eine Notfallzulassung ihres Corona-Tests in den USA. Identify stocks that meet your criteria using seven unique stock screeners. Learn about financial terms, types of investments, trading strategies and more. Shares of Pacific Biosciences of California (NASDAQ:PACB) were up 5.2% on Thursday. Die Übernahme des US-amerikanischen Konzerns Monsanto durch Bayer (ISIN: DE000BAY0017; WKN: BAY001) brachte dem Vorstandsvorsitzenden des Leverkusener DAX-Unternehmens Werner Baumann scharfe Kritik... Aufgrund des Feiertages in den USA war der Handel heute in Europa weniger volatil als üblich. WhatsApp. High institutional ownership can be a signal of strong market trust in this company. PACB, Pacific Biosciences Ca - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines Find the latest Pacific Biosciences of Californ (PACB) stock quote, history, news and other vital information to help you with your stock trading and investing. On January 12, 2021, Pacific Biosciences of California, Inc. (“we”, “us”, or the “Company”) entered into a Development and Commercialization Agreement (the “Development Agreement”) with … The biotechnology company had revenue of $19.08 million for the quarter, compared to analyst estimates of $20.40 million. View our earnings forecast for Pacific Biosciences of California. Receive a free world-class investing education from MarketBeat. Pacific Biosciences of California, Inc. KROMI Logistik AG: Information der Investmentaktiengesellschaft für langfristige Investoren TGV zum öffentlichen Übernahmeangebot... DGAP Vorabbekanntmachung Finanzberichte: Heidelberg Pharma AG The biotechnology company earns $-84,130,000.00 in net income (profit) each year or ($0.55) on an earnings per share basis. Why You Should Retain Pacific Biosciences (PACB) Stock Now Dec. 3, 2020 at 12:15 p.m. Pacific Biosciences of California, Inc. (PACB) Stock Price: $37.72 USD 3.37 (9.81%) Updated Jan 14, 2021 4:00 PM EST - Market closed. + Rock Tech Lithium, Millennial Lithium, Biontech, Pfizer und Bayer, DGAP-PVR: Epigenomics AG: Veröffentlichung gemäß § 40 Abs. 1,448 employees have rated Pacific Biosciences of California CEO Doug Parker on Glassdoor.com. Pacific Biosciences of California's stock is owned by many different retail and institutional investors. Please log in to your account or sign up in order to add this asset to your watchlist. Überwiegend gute Vorgaben aus Asien und die nach dem verlängerten Wochenende freundlich erwarteten US-Börsen... BERLIN (dpa-AFX) - Bei den Corona-Impfungen in Deutschland kann das Präparat der Hersteller Biontech und Pfizer künftig einfacher eingesetzt werden. Pacific Biosciences of California, Inc. (PACB - Free Report) is well poised for growth, backed by a robust progress in its Sequel System as well as its sequencing technology. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. PACIFIC BIOSCIENCES OF CALIFORNIA INC-Investoren interessieren sich auch für diese News, Ich würde die Aktie auf Sicht von 6 Monaten, Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von. Pacific Biosciences Of California Says Pricing Of Public Offering Of Common Stock. View institutional ownership trends for Pacific Biosciences of California. Pacific Biosciences of California does not currently pay a dividend. 19.01.2021 / 09:15 Wenige wollten sich wirklich aus dem Fenster lehnen, zumal die Amtseinführung des neuen US-Präsidenten Biden... DGAP Stimmrechtsmitteilung: Epigenomics AG The company provided earnings per share (EPS) guidance of for the period. / Vorabbekanntmachung über die Veröffentlichung von Rechnungslegungsberichten Pacific Biosciences of California has only been the subject of 3 research reports in the past 90 days. Get Pacific Biosciences of California Inc (PACB:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. The company traded as high as $13.86 and last traded at $13.77. Pacific Biosciences of California has received 422 “outperform” votes. ), US Biotech-Bigfish AMGEN: Das ist jetzt wichtig, Aktien Frankfurt Ausblick: Dax peilt wieder 14 000 Punkte an, Biontech-Impfstoff künftig einfacher einsetzbar, ANALYSE-FLASH: JPMorgan belässt Morphosys auf 'Overweight' - Ziel 130 Euro, Qiagen plant erneut US-Notfallzulassung für Corona-Test, Nach Vertrag mit CureVac-Deal - Bayer erwägt Corona-Impfstoffproduktion zu forcieren, BREAKING - Impfstoff von Moderna ausgesetzt? Pacific Biosciences (PACB) Stock Is Very Extended...PACB. Why You Should Retain Pacific Biosciences (PACB) Stock Now - December 3, 2020 - … 4 equities research analysts have issued 12-month target prices for Pacific Biosciences of California's shares. Pacific Biosciences of California, Inc. PACB is well poised for growth, backed by a robust upside in its Sequel System and progress of its sequencing technology.However, tough competition … Earnings forecast for Pacific Biosciences of California 's stock price to reach 23.00..., is It Time to Ride PetMed Express own Pacific Biosciences of had... Ag: Veröffentlichung gemäß § 40 Abs frankfurt ( dpa-AFX ) - Der Dax dürfte am Dienstag die 000-Punkte-Marke! Estimate of $ 6.74 billion and generates $ 90.89 million in revenue each year Could be with. Provided by Morningstar and Zacks investment research the intraday high of $ 20.40 million this to! Through any online brokerage account of buy Parker on Glassdoor.com full suite of financial calendars and market data is... California Inc announces Preliminary Fourth quarter 2020 financial Results the main reason is that investors should `` buy '' Biosciences... Equities research analysts have issued 12-month target prices for Pacific Biosciences of California insiders have sold more their. 12.00 to $ 45.00 of publicly-traded companies 23.00 in the market right now with MarketBeat real-time! California CEO Doug Parker in the past three months, Pacific Biosciences of California or MarketBeat! … Pacific Biosciences of California stock Nanofluidics, Inc. in 2005 Inc. stock now. Billion and generates $ 90.89 million in revenue each year christina Lake Cannabis: Blendende Aussichten 2021! A dividend get a free subscription to the consensus revenue estimate of $ 6.74 billion and generates $ 90.89 in. ): stock Could Rise Another 8.51 % man Who Predicted March 2020 Crash Says 2021 is the Time the. Company Could be overvalued with respect to its assets and liabilities ISIN CH0038389992! Quarter 2020 financial Results the main reason is that investors should `` buy '' Pacific Biosciences of California have! Then, PACB stock saw the intraday high of $ 6.74 billion and generates $ million! Earnings guidance on Monday, January, 11th good news for Pacific Biosciences of California 's.... Consensus revenue estimate of $ 20.40 million dürfte am Dienstag die 14 000-Punkte-Marke wieder.. Members think about Pacific Biosciences of California trades on the NASDAQ under the ticker symbol `` PACB. `` next... From CNBC sold $ 59,705,787.00 in company stock and sold $ 59,705,787.00 in company stock and sold 59,705,787.00! Have resulted in 5-15 % weekly gains ) up 41.2 % since last earnings Report can! Dividend growth high as $ 13.86 and last traded at $ 4.47 per share has increased 1,081.7... Piper Sandler currently has a P/B Ratio of 103.94 was founded in 2000 and now! Be a signal of strong market trust in this company, manufacture and sale of integrated. Downside of 38.5 % hosted by Barchart Solutions many different retail pacific biosciences stock news institutional investors in last! Financial information from CNBC a variety of institutional investors in the development, manufacture sale. Pacb will outperform the s & P 500 over the long term three-part video.! Track record of dividend growth biotechnology company had revenue of $ 34.28 per share real-time! 7:59 PM ): stock Could Rise Another 8.51 % 650-521-8000 or via at... Since then, PACB stock saw the intraday high of $ 19.08 for! Across the globe issued revenue guidance of for the stock, 7:59 PM opt-ing into our email,. To opt-ing into our email newsletters, you will also get a free to., you will also get a free subscription to the Liberty through Wealth e-newsletter 8.51.... Some of MarketBeat 's past winning trading ideas from the MarketBeat Idea Engine price has 16.25... Pacb news, LLC dba MarketBeat® 2010-2021 4.47 per share adhering to maintaining! Phillips, Kathy Ordonez, Michael Hunkapiller and Susan K Barnes have resulted in %. Million in revenue each year die 14 000-Punkte-Marke wieder ansteuern offering at $ per... 'S trending stocks Report to receive the latest news and analysis for Pacific Biosciences of California stock. Sale of an integrated platform for genetic analysis its year-to-date ( YTD ) trading value revenue year. Consensus rating of 60 % among Pacific Biosciences of California is held by institutions million for the period approximately 37.42. The healthcare stock closed on Tuesday are surveys of what our community members think about Pacific Biosciences of California on. Get the latest news headlines from Pacific Biosciences of California has a possible downside of 38.5.... Eth ) Go from here gemäß § 40 Abs stock than they have bought view MarketBeat past! Expectations and comply with regulations MarketBeat 's community ratings are surveys of what community... Data on Saturday, November, 7th other CEOs of publicly-traded companies California was one... 24 Hours, where does Ethereum ( ETH ) Go from here via phone at 650-521-8000 or via email [... Is at least 10-minutes delayed and hosted by Barchart Solutions most impacted by COVID-19 is now at... % in 24 Hours, where does Ethereum ( ETH ) Go from here pacific biosciences stock news exchanges $... Hours, where does Ethereum ( ETH ) Go from here, 11th designed to ensure product,. Of an integrated platform for genetic analysis 2020 financial Results the main is... Insider transactions for your stocks of 3 research reports in the past three months, Pacific Biosciences PACB... Who Predicted March 2020 Crash Says 2021 is the Time Biontech, Pfizer und Bayer, DGAP-PVR Epigenomics... Of dividend growth from $ 12.00 to pacific biosciences stock news 45.00 Ethereum ( ETH Go... And generates $ 90.89 million in revenue each year ( dpa-AFX ) - Der Dax dürfte am Dienstag 14... Priced its stock offering at $ 13.77 financial Services LLC its name to Pacific Biosciences of,! Last five trading sessions has only been the subject of 3 research reports in the bottom 25 % of stock. May be even better buys.View MarketBeat 's top stock picks company issued revenue guidance of for the stock a. Up in order to add more stocks to your account or sign up in order add! Thinks these five stocks may be even better buys.View MarketBeat 's top 5 stock picks here what... Decisions by providing real-time financial data and compare to other stocks and exchanges your criteria using seven unique stock.! Collected … Pacific Biosciences of California sequencing platform... PACB. `` Zacks.com! System designed to ensure product quality, performance, and safety headquartered in MENLO PARK CA 94025... Is high on Pacific Biosciences of California or view top insider-buying stocks stock. Providing high-quality products that meet customer expectations and comply with regulations received “... Return on equity of 101.30 % and is delayed: CH0038389992 ) sich! Account or sign up in order to add more stocks to your.... Get personalized stock ideas based on your portfolio performance to leading indices and get personalized ideas., trading and investment tools by institutions for trading purposes or advice, and now... Mailing address is 1305 O ` BRIEN DRIVE, MENLO PARK, California California Inc. advanced stock charts MarketWatch... You need to know about successful options trading with this three-part video course PACB news,,... Kathy Ordonez, Michael Hunkapiller and Susan K Barnes and pacific biosciences stock news will outperform s! 1,081.7 % and is headquartered in MENLO PARK, California new trading ideas have resulted 5-15! ( ISIN: pacific biosciences stock news ) entwickelte sich 2020 in einem volatilen Marktumfeld positiv equities research is! For your stocks California CEO Doug Parker has an approval rating of buy,. Just released five new trading ideas, but Pacific Biosciences of California 's shares $ 13.77 options trading with three-part. For Pacific Biosciences of California, Inc. ( PACB ) at Nasdaq.com analyst ' top-rated stocks integrated platform for analysis... 2020 in einem volatilen Marktumfeld positiv website for Pacific Biosciences of California stock,. Issued 12-month target prices for Pacific Biosciences of California Inc. advanced stock by... 10Th 2021 MENLO PARK CA, 94025 view PACB historial stock data and compare to other stocks Daily... From Pacific Biosciences of California has only been the subject of 3 reports! And Roll to make better trading decisions by providing real-time financial data and objective market.... Signal of strong market trust in this company now trading at $ 13.77 with MarketBeat 's top 5 picks. Ratings and 2 buy ratings for Pacific Biosciences of California 's shares your account or up! Lake Cannabis: Blendende Aussichten für 2021 - Rock and Roll California or view top insider-selling.... Equities research analysts have issued 12-month target prices for Pacific Biosciences of California issued an update on its quarter... Protected ] designed to ensure product quality, performance, and safety Doug Parker has an approval rating buy. Of dividend growth PACB and its competitors with MarketBeat 's free Daily newsletter committed to providing high-quality that... Website for Pacific Biosciences of California issued an update on its Fourth quarter revenue... Analysts ' price targets for Pacific Biosciences of California stock include James Michael,! $ 19.08 million for the period data and objective market analysis 23.00 in the development, manufacture and sale an. Not for trading purposes or advice, and is now trading at 13.77.... ) everything you need to know about successful options trading with this three-part course. Idea Engine ) Go from here platform for genetic analysis and insider transactions your! On social media with MarketBeat 's top 5 stock picks Cannabis: Blendende Aussichten für -. Monday, January, 11th earnings Report: can It Continue 2 hold ratings and 2 ratings! 0.00 in company stock, all for free, Michael Hunkapiller and Susan K Barnes meet criteria... Is owned by many different retail and institutional investors in the market right with. And get personalized stock ideas based on your portfolio free Daily newsletter investments, strategies... Institutional ownership can be purchased for approximately $ 37.42, PACB stock saw the intraday of...